Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)
Reducing Mortality in Adults With Advanced HIV Disease, a Double Blinded Randomized Trial
Population Health Research Institute
8,000 participants
May 8, 2023
INTERVENTIONAL
Conditions
Summary
A double blinded, placebo-controlled, multicenter trial to evaluate effectiveness of azithromycin prophylaxis on mortality in advanced HIV.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Antimicrobial therapy
Inert ingredients
Locations(52)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05580666